Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Ave J2-2, Cleveland, OH, USA.
Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Europace. 2019 Oct 1;21(10):1476-1483. doi: 10.1093/europace/euz183.
Obesity decreases arrhythmia-free survival after atrial fibrillation (AF) ablation by mechanisms that are not fully understood. We investigated the impact of pre-ablation bariatric surgery (BS) on AF recurrence after ablation.
In this retrospective observational cohort study, 239 consecutive morbidly obese patients (body mass index ≥40 kg/m2 or ≥35 kg/m2 with obesity-related complications) were followed for a mean of 22 months prior to ablation. Of these patients, 51 had BS prior to ablation, and our primary outcome was whether BS was associated with a lower rate of AF recurrence during follow-up. Adjustment for confounding was performed with multivariable Cox proportional hazard models and propensity-score based analyses. During a mean follow-up of 36 months after ablation, 10/51 patients (20%) in the BS group had recurrent AF compared with 114/188 (61%) in the non-BS group (P < 0.0001). In the BS group, 6 patients (12%) underwent repeat ablation compared with 77 patients (41%) in the non-BS group, (P < 0.0001). On multivariable analysis, the association between BS and lower AF recurrence remained significant. Similarly, after weighting and adjusting for the inverse probability of the propensity score, BS was still associated with a lower hazard of AF recurrence (hazard ratio 0.14, 95% confidence interval 0.05-0.39; P = 0.002).
Bariatric surgery is associated with a lower AF recurrence after ablation. Morbidly obese patients should be considered for BS prior to AF ablation, though prospective multicentre studies should be performed to confirm our novel finding.
肥胖通过尚未完全阐明的机制降低了房颤(AF)消融后的无心律失常生存。我们研究了消融前减重手术(BS)对消融后 AF 复发的影响。
在这项回顾性观察队列研究中,对 239 例连续的病态肥胖患者(BMI≥40kg/m2或≥35kg/m2 伴肥胖相关并发症)进行了平均 22 个月的消融前随访。其中 51 例患者在消融前进行了 BS,我们的主要终点是 BS 是否与随访期间 AF 复发率降低相关。采用多变量 Cox 比例风险模型和倾向评分匹配分析进行混杂因素调整。在消融后平均 36 个月的随访期间,BS 组有 10/51 例(20%)患者发生复发性 AF,而非 BS 组有 114/188 例(61%)患者发生复发性 AF(P<0.0001)。BS 组中有 6 例(12%)患者需要再次消融,而非 BS 组中有 77 例(41%)患者需要再次消融(P<0.0001)。多变量分析显示,BS 与较低的 AF 复发率之间仍存在显著关联。同样,在加权和调整倾向评分的逆概率后,BS 与较低的 AF 复发风险仍然相关(风险比 0.14,95%置信区间 0.05-0.39;P=0.002)。
BS 与消融后 AF 复发率降低相关。对于计划进行 AF 消融的病态肥胖患者,应考虑进行 BS,尽管应开展前瞻性多中心研究以证实我们的这一新发现。